You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Sao Paulo state in Brazil asks approval to use Sinovac Covid-19 vaccine

Sao Paulo, Brazil's most populous state, is one of the sites of Phase III clinical trials for the Sinovac vaccine conducted by the state's Butantan Institute, a leading biomedical research center

Topics
Coronavirus Vaccine | Brazil | Coronavirus

Reuters  |  Sao Paulo 

The government of Sao Paulo state in Brazil has asked health regulator Anvisa to register for use the Covid-19 vaccine candidate developed by China's Sinovac Biotech Ltd, governor Joao Doria said on Friday, a major step in what could be one of the first vaccination programs in the Americas. Doria has said he plans to begin inoculating the population of Sao Paulo with the Sinovac vaccine by mid-December, one of the world's most aggressive timelines outside China and Russia. Before he is able to do so, he requires approval from Anvisa. Shortly after Doria's statement, the ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Sat, October 03 2020. 16:45 IST
RECOMMENDED FOR YOU